E Berntorp1, I M Nilsson. Show Affiliations » 1. Department for Coagulation Disorders University Hospital, Malmö, Sweden.
Abstract
Mesh： See more » AdolescentAdultAgedChildChild, PreschoolClinical ProtocolsCysteine Endopeptidases/immunologyCysteine Endopeptidases/therapeutic useFactor IXa/immunologyFactor IXa/therapeutic useFactor VIIIa/immunologyFactor VIIIa/therapeutic useHemophilia A/drug therapyHemophilia A/immunologyHemophilia B/drug therapyHemophilia B/immunologyHumansImmune Tolerance/drug effectsImmunosorbent TechniquesMiddle AgedNeoplasm Proteins
Substances： See more » Neoplasm ProteinsFactor VIIIaFactor IXaCysteine Endopeptidasescancer procoagulant
Year: 1996 PMID： 8869467
Source DB: PubMed Journal: Vox Sang ISSN： 0042-9007 Impact factor: 2.144